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Abstract.  The p62/E2 protein of Semliki Forest virus 
(SFV) is a typical transmembrane glycoprotein, with 
an amino-terminal  lumenal domain, a transmem- 
brane (hydrophobic) domain, and a carboxy-terminal 
cytoplasmic domain (or tail). Our hypothesis has been 
that the membrane-binding polypeptide region (mem- 
brane anchor) of this protein consists of both the 
transmembrane domain and the adjacent positively 
charged peptide, Arg-Ser-Lys, which is part of the cy- 
toplasmic domain. We have investigated three anchor 
mutants of the p62 protein with respect to both their 
disposition and their stability in cell membranes. The 
construction of the three mutants has been described 
(Cutler, D. F., and H. Garoff, J.  Cell Biol.,  102:889- 
901 ). They are as follows: A 1, changing the basic 
charge cluster from Arg-Ser-Lys(+2) to Gly-Ser- 
Glu(- 1); A2, replacing an Ala in the middle of the 
hydrophobic stretch with a Glu; A3, changing the 
charge cluster from Arg-Ser-Lys(+2) to Gly-Ser- 
Met(0). All three mutants retain the transmembrane 
configuration of the wild-type p62. In a cell homog- 
enate they have a cytoplasmic domain that is accessi- 
ble to protease. In living cells an anti-peptide antibody 
specific for the cytoplasmic tail of p62 reacts with the 
tails of both wild-type and mutant p62s following its 
introduction into the cytoplasm. All three mutant 
proteins have Triton X-114 binding properties similar 
to the wild-type p62. However, when the membranes 
of cells expressing the three mutants or the wild-type 
p62 protein are washed with sodium carbonate, pH 
11.5, three to four times as much mutant protein as 
wild-type p62 is released from the membranes. Thus 
the stability in cell membranes of the three mutant 
p62 proteins is significantly reduced. 
T 
HE Semliki  Forest virus  (SFV)  t p62/E2  protein is a 
typical example  of the transmembrane glycoproteins 
that  span  the  membrane  once,  with  a  large NH2- 
terminal  lumenal  domain,  a  transmembrane  domain  (fol- 
lowed by two closely spaced basic amino acids), and a small 
COOH-terminal  cytoplasmic domain (8, 14, 20). This topol- 
ogy  is  most  likely  generated  co-translationally  by halting 
transfer through the membrane. As discussed in the preceding 
paper,  it  has  been our working  hypothesis  that  the region 
containing  the transmembrane  (hydrophobic)  domain  and 
the charge cluster,  from now on referred to as membrane- 
binding region or anchor, is responsible for the establishment 
and maintenance  of this topology. To test this hypothesis, we 
have made a series of point mutations in the cDNA encoding 
the SFV structural  proteins  (see the preceding paper). These 
mutations change the basic charge cluster which follows the 
p62  spanning  region from +2 (wild-type Arg-Ser-Lys) to 0 
(SFV-A3, Gly-Ser-Met) or -1 (SFV-A 1, Gly-Ser-Glu) or in- 
troduce a glutamic  acid into the middle of the hydrophobic 
stretch (SFV-A2). We have already shown (see the preceding 
Abbreviation used in this paper." SFV, Semliki Forest  virus. 
paper) that the proteins made from the DNA encoding these 
mutants are of the predicted  size and are glycosylated. The 
membrane association of all three mutants was functionally 
unaltered  as assayed by cell surface transport  and ability to 
promote cell-cell fusion. 
In this paper, we investigate the transmembrane  topology 
and membrane binding of the mutants directly. Since there is 
no loss of functional  membrane association  for the charge 
cluster  mutants of p62,  we expect the hydrophobic  stretch 
and not the charge cluster to play the major role in mem- 
brane-protein interaction.  However, the precise topology of 
this interaction  might be defined by the charge cluster. For 
example,  A3, which  has  completely  lost  its charge cluster, 
might have passed through  the bilayer and might be bound 
to the lumenal  face of the membrane via the hydrophobic 
stretch without retaining  a cytoplasmic  domain.  If a single 
negatively charged amino acid could act to maintain  normal 
topology, then A 1 (with the charge cluster replaced by Glu) 
might still span the bilayer. If A 1 were still transmembrane, 
then  transfer  of A2  (with  a  Glu  replacing  an  Ala  in  the 
hydrophobic stretch) might be halted earlier, and/or stabilized 
in a new position by the introduced glutamic acid. A2 would 
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hydrophobic as the region thought to span the bilayer, the 
region immediately upstream consists mainly of uncharged 
and hydrophobic amino acids (see  Fig.  1 of the  preceding 
paper). Alternatively, the charge cluster may only serve to 
increase stability in the membrane and to provide a  sharp 
distinction between membrane and cytoplasmic domains. In 
this  case,  AI  and  A3  shouM  not  have  a  large  effect on 
topology, being manifested instead in a decreased capacity for 
membrane binding, possibly coupled to a minor repositioning 
of the mutant polypeptide chains in the membrane. More- 
over, since the primary interaction between lipid bilayer and 
protein is most likely through the hydrophobic stretch of the 
latter, we would also expect A2 to show similar tendencies. 
Our results show that all three mutants still span the bilayer, 
with a  reagent-accessible cytoplasmic tail We also demon- 
strate that all three have a reduced membrane-binding capac- 
ity compared to wild-type p62. 
Materials and Methods 
All methods not detailed here are described in the preceding paper. 
Antibody Microinjection Experiments 
The method for these experiments and the characterization  of the anti-peptide 
antibody  are detailed  elsewhere (Roman L., and  H.  Garoff,  manuscript in 
preparationL  Briefly, the  nuclei of 100 BHK-21 cetis were injected (18) with 
pS-S-SFV (see preceding paper) containing  wild-type or mutant p62-encoding 
sequences. After 6 h at 37(7, the cells were injected with affinity-purified anti- 
peptide antibody  at 0.8  mg/ml or with a  monoclonal  anti-E2  antibody  that 
reacts against the lumenal domain of E2 (Roman, L., unpublished data) at 0.8 
mg/ml. These cells were then fixed in methanol and stained with fluorescent 
second antibodies. Surface staining with the same two antibodies was performed 
(see above) on cells that had been microinjected with DNA as above and then 
gluteraldehyde fixed at 6 h. For surface staining, the anti-peptide antibody was 
diluted  100-fold, the monoclonal  antibody 50-fold. 
Preparation of  Microsomes 
5-cm dishes of transfected cells were placed on ice and rinsed (twice) with ice- 
cold phosphate-buffered  saline.  1 ml phosphate-buffered  saline with Trypsin 
(0_05%) and EDTA (0.02%) was added and the cells rocked at 37(7 for 5 rain. 
The trypsinized ceils were pelleted at 2,000 tom at 4(7 for 3 min, followed by 
two washes with sucrose buffer (0.25 M sucrose,  10 mM Tris, pH 7.5, 1 mM 
MgCI2). The cells were then suspended in 30 ~,1 sucrose buffer per 5-cm dish 
starting material. The suspension was firmly passed through a 25-td Hamilton 
synnge nine times, diluted to 200/~l/dish with sucrose buffer, and passed once 
through a  100-ul Hamilton syringe. Nuclei were spun out in a microfuge at 
4"C, 3 min, and the "microsomal" preparation  was removed to a fresh tube. 
Protease Protection Experiments 
Five dishes of cells were used for each probe. 30 h after transfection, cells were 
labeled for 20 min followed by a 5-min chase. A microsomal preparation  was 
performed (see above) and the cell homogenates were split into three. Samples 
were incubated  for 30 min at 20"C with proteinase K (Boehringer Mannheim 
Biochemicals, Indianapolis,  IN) (2 mg/ml), or proteinase K and Triton X-100 
(1%), or neither.  Phenyimethylsulfonyl  fluoride was then added  to 2  raM. 
Samples  without  detergent  were  then  spun at  t00,000  g  for  1 h  and  the 
membrane pellet was solubilized in immunoprecipitation  buffer. The sample 
with detergent was adjusted to immunoprecipitation  buffer (see previous paper). 
Immunoprecipitation was followed by gel electrophoresis (9) and fluorography. 
Carbonate Experiments 
40  h  after  transfection,  5-cm  dishes  of cells were  homogenized  to  give a 
microsomal preparation.  This procedure was modified by diluting each sample 
to 300 ul before the final syringing. 300 #1 of the sodium carbonate  or NaOH 
solution  (7,  15) was then added  to the postnuclear  supernatant and the mix 
passed once more through a  100-/~1 Hamilton syringe, and left on ice for 20 
rain.  Membranes were pelleted by a  100,000 g spin for 1 h at 4(7 in cellulose 
nitrate tubes (Beckman Instruments Inc., Palo Alto, CA) of diameter  3/16 x 
1-21/32 inches through a 25% sucrose cushion (50 t.d)- The tubes were spun in 
an SW50 rotor using the appropriate  adaptor.  The superuatant  was removed, 
trichloroacetic acid precipitated, and dissolved in sample buffer for gel electro- 
phoresis_ The pellet was rinsed with distilled water and dissolved directly in 
sample buffer. 
Triton X-114 Partitioning 
40 h after transfection, 5-era dishes of cells (2 dishes/probe) were placed on ice 
and washed twice with ice-cold phosphate-buffered saline. 0.5 ml of cold saline 
made  1% with Triton X-114 (4) was added and left for 5 rain. The ceils were 
solubilized by pipetting up and down with a Gilson pipetman,  and insoluble 
material was removed by spinning 5 min at 4(7 in a microfuge. The supernatant 
was heated to 37(7  for 5 rain, spun at 1,000 rpm at 37(7 for 5 min, and the 
supernatant and pellet (aqueous and detergent) phases were separated (4). The 
aqueous phase was trichloroacetic acid precipitated and solubiiized in sample 
buffer. The detergent phase was solubilized in sample buffer with added SDS 
(final concentration  of 6%). 
Results 
Transmembrane Topology of the SFV-A Mutants 
The question of topology has been investigated using two 
complementary approaches. Both were designed to test the 
mutated p62 proteins for a cytoplasmic domain that was still 
accessible to reagents. The first approach involved labeling of 
the cytoplasmic tail by microinjection of an anti-E2 COOH- 
terminal  peptide antibody into  living  cells  expressing the 
mutant  protein--a  nonperturbing  approach.  The  second 
method was the classical protease-protection experiment; iso- 
lation of microsomes from transfected cells and digestion of 
their cytoplasmic face with a protease followed by immuno- 
precipitation and electrophoretic analysis. The two independ- 
ent approaches have different advantages. The microinjection 
experiment reveals the topology in vivo, and moreover avoids 
the possibility of potential artefacts arising during microsome 
isolation. On the other hand, a protease-protection experi- 
ment can give the approximate size of  the cytoplasmic domain 
and moreover can reveal how much heterogeneity of  topology 
for each mutant p62 exists. Together, the two approaches, in 
vivo and in vitro, should provide a comprehensive answer to 
this important question. 
In Vivo Topology 
The in  vivo topology of the  mutants  was  investigated by 
microinjecting, within a delineated region of a coverslip, the 
nuclei of all the BHK-21 cells present (~ 100 cells) with pS-S- 
SFV containing wild-type or mutant DNAs.  pS-S-SFV  is a 
plasmid where transcription of  the SFV eDNA is driven from 
the SV40 early promoter (see preceding paper and reference 
9). 6-7 h were allowed for expression of viral proteins to peak 
(18)  and  then  the  cells  within  the  same  area  were  again 
microinjected with either a monoclonal anti-E2 lumenal do- 
main antibody (control) or a polyclonal anti-E2 cytoplasmic 
tail antibody. This antibody only recognizes the cytoplasmic 
domain of p62/E2 (Roman, L., and H. Garoff, manuscript 
in preparation). The cells were incubated for half an hour and 
then  fixed/permeabilized and  stained  with  a  rhodamine- 
conjugated second antibody. As a further control, microin- 
jected cells were fixed after 6-7 h and the surface stained with 
either of the two antibodies. The results (Fig. 1) show that the 
anti-COOH-terminal peptide antibody does stain  all three 
mutants from the cytoplasmic side ofintracellular membranes 
(cells injected with antibody) (a), but not from the outside of 
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A  mutants.  The  nuclei of BHK-21 
cells were microinjected with  pS-S- 
SFV (see preceding paper) encoding 
the  wild-type (WT)  or  mutant  (A1, 
A2, and A3) p62 i~roteir~s. 6 h later the 
cells were microinjected wilh an anti- 
cytoplasmic tail anti-peptide antibody 
(a) or with an anti-lumenal  domain 
antibody (c). Alternatively, 6 h after 
microinjection  of DNA, cells were 
fixed and then stained on the surface 
with anti-cytoplasmic tail antibody (b) 
or anti-lumenal domain antibody (d). 
In all cases, staining with a fluorescent 
second antibody  followed. Immuno- 
fluorescent  and  corresponding  No- 
marski micrographs are shown. Bar, 
20 urn. The left-hand panel shows the 
wild-type and  A I  p62 proteins. The 
right-hand panel (facing page) shows 
the A2 and A3 p62 proteins. 
cells (b). The anti-lumenal domain antibody only stains from 
the outside of cells (d) and not from the cytoplasm (c). The 
pattern of internal  staining concentrated  in the perinuclear 
region, seen using the anti-COOH-terminal antibody is sim- 
ilar to that  obtained  in  infected  cells (Roman,  U,  and  H. 
Garoff, manuscript in preparation). Thus, the concentration 
of spike glycoprotein in the Golgi apparatus observed during 
infection (12) can also be detected after microinjection (Fig. 
1  a). The brightness of fluorescence seen after microinjection 
of  the anti-peptide antibody (Fig.  1  a) varies considerably from 
cell to cell and from experiment to experiment, both for the 
three  mutants and  for the  wild-type p62/E2  proteins.  The 
level of background staining after microinjection of antibody 
was consistently higher than  that  seen  for surface  staining 
(compare Fig.  1, b with c). We conclude from these experi- 
ments that a significant fraction of each population of mutant 
p62  proteins has the  wild-type transmembrane topology in 
vivo. 
In Vitro Topology of the SFV-A Mutants 
In vivo and in the presence of El, the SFV-A mutants of p62 
appear to show unaltered topology. For the in vitro assay, p62 
was analyzed in the absence of El. The rationale for this was 
that E1  may stabilize E2 in the membrane through interac- 
tions between the two halves of  the heterodimer spike complex 
and thus mask differences between wild-type and mutant p62. 
For this purpose we used the pLI-SFV-d9 plasmids. In these 
plasmids, the portion of the SFV cDNA encoding E I and the 
carboxyl half of the 6K peptide are deleted. The 6K peptide 
is normally synthesized  after E2  and before El.  When  ex- 
pressed from pL1-SFV-d9,  the  normally occurring p62-6K 
cleavage ensures that p62 with an authentic COOH-terminus 
is produced (see preceding paper for details). 
COS-7 cells were transfected with pL1-SFV-d9 or the same 
plasmid containing the three mutants. These cells express the 
SV40 T-antigen endogenously and therefore promote repli- 
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cDNAs from the SV40 late promoter. 30 h after transfection, 
the cells  were pulse-labeled and a  microsomal fraction was 
prepared. The microsomes were divided into three aliquots 
and incubated either with proteinase K, or proteinase K plus 
Triton X-100, or with neither. After incubation, the remain- 
ing p62  was  immunoprecipitated, electrophoresed on  SDS 
polyacrylamide  gels, and fluorographed. The fluorograph (Fig. 
2) shows that for the wild-type and all three mutants a shift 
in molecular weight, presumably due to loss of the protease- 
accessible cytoplasmic domain, occurs when protease is added 
(compare lanes  l, 4, 7, and  l0 with 2, 5, 8, and  I 1). In the 
presence of both proteinase K and Triton X-100, the p62 is 
completely digested (lanes 3, 6, 9, and  12). The size of the 
change  in  molecular  weight  in  each  case  is  similar.  The 
shaving of the  cytoplasmic domain  is  complete with  each 
mutant, as with the wild type; all polypeptide chains of each 
population are transmembrane.  Thus both in  vivo and  in 
vitro the three SFV-A  mutants  are clearly transmembrane 
with a cytoplasmic domain accessible to reagents. 
Membrane Binding of the SFV-A Mutants 
Two biochemical assays for the membrane-binding capacity 
of the mutant and wild-type p62s have been used. The parti- 
tioning of  the proteins between aqueous and detergent (Triton 
X-114) phases assays for general hydrophobicity. The second 
assay  is  of release of 1362 from cellular membranes when 
treated with the protein perturbant sodium carbonate at pH 
11.5. 
Triton X-114 Binding of the SFV-A Mutants 
The partitioning of protein between an aqueous phase and 
Triton X- 114 has been proposed as an operational distinction 
between membrane-bound and unbound proteins (4). More 
recently, it has been suggested that partitioning measures the 
general surface hydrophobicity of proteins (3). If  this property 
905  Cutler el al. Topology  and Membrane  Binding Figure 2 . In vitro topology of the SFV-A mutants . COS-7 cells were transfected with the mutant and wild-type forms ofpLl-SFV-d9 (d9A1,
d9Á2, d9Á3, and d9 respectively) . 30 h later, cells were labeled, homogenized, and samples were incubated with proteinase K, proteinase K
plus Triton X-100, or neither. Samples were then immunoprecipitated with affinity-purified anti-E2 antibody and electrophoresed on a 10%
SDS polyacrylamide gel which was fluorographed . Samples transfected and presence (+) or absence (-) of Triton X-100 and proteinase K are
indicated in lane headings . C indicates nontransfected cells. Input from - 1 .5 x 106 cells is loaded on each lane . Migration of molecular mass
standards (kD) is shown .
has been significantly altered in any ofthe mutants by changes
made in or around the most hydrophobic portion of p62 (8)
this could clearly affect its detergent-binding properties which
may in turn reflect its membrane-binding capacity . Accord-
ingly, COS-7 cellswere transfected with thepL1-SFV-d9 series
of plasmids, left for 40 h, and then solubilized in a solution
of Triton X-114 . Partitioning was effected, and supernatant,
pellet, and input fractions electrophoresed on an SDS poly-
acrylamide gel. The proteins were transferred to nitrocellulose
and incubated with a mixture of anti-E2 and anti-capsid
polyclonal antibodies followed by a peroxidase-conjugated
second antibody. The partitioning of capsid was monitored
to provide a control cytoplasmic protein . The blot was stained
using the peroxidase/diaminobenzidine/H202 reaction . To
ensure that there were no differences between p62s produced
in the presence and absence of El 40 h after transfection,
wild-type pLl-SFV DNA was transfected in parallel and
blotted . The blot (Fig. 3) reveals that all the p62s partition
approximately equally between pellet (detergent phase: lanes
2, 5, 8, and 11) and supernatant (aqueous phase: lanes 3, 6,
9, and 12). No major differences are seen. Capsid partitions
mainly into the aqueous phase .
The same experiment has been performed with the mutant
proteins expressed from pLl-SFV A1, A2, and A3 (data not
shown) . In these analyses, most of the p62 was found to be
cleaved to E2 as in the case of the wild-type pLl-SFV (see
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above) . The remaining p62 protein and the E2 form of the
mutants partitioned in the Triton X-114 assay as the corre-
sponding wild-type protein forms shown in lane 1 of Fig . 3 .
The p62 proteins partitioned about equally in both phases
whereas the E2 form was almost quantitatively found in the
detergent phase. Presumably, the relatively hydrophilic E3
part ofp62 (the E3-E2 precursor; references 8 and 14) forces
this protein into the aqueous phase to some extent. A surpris-
ing difference between pLI-SFV and pLI-SFV-d9 lies in the
amount of capsid found : much less capsid is found in the
presence of E 1 than in its absence . This is a consistent and
repeatable observation (Cutler, D ., andP. Melancon, unpub-
lished observations) for whichwe have no explanation . More-
over, capsid in this system runs as a doublet (both these bands
disappear when anti-capsid antibody is not used) . This may
be due to partial posttranslational modification (e.g., reference
17) .
Carbonate Extraction ofSFV-A Mutants
Many protein perturbants have been used to extract proteins
from membranes. The differential release of proteins from
membranes following the use of such reagents may reflect
heterogeneity in the association of those proteins with the
membrane (15) .To look for differences inmembrane binding
between the wild-type and the A-mutants of the SFV-p62
protein we have therefore used an extraction procedure using
906Figure 3 . Triton X-114binding ofSFV-A mutants . Two5-cm dishes ofCOS-7 cells were transfected with wild-type and mutant p62s in pLl-
SFV-d9 (d9, d9A1, d9A2, and d9A3, respectively) and with the wild-type p62 in pLI-SFV (R'7) .After 40 h, cells were lysed with Triton X-
114 . One-half of each sample was partitioned before electrophoresis to give aqueous (S, supernatant) or detergent (P, pellet) phases and the
other half electrophoresed directly (-) on a 10% SDS polyacrylamide gel. The proteins were transferred to nitrocellulose, and incubated with a
mixture ofanti-E2 and anti-capsid IgG fractions followed by peroxidase-conjugated sheep anti-rabbit IgG . The filter was stained with the HzO2/
diaminobenzidine reaction. All of each sample was loaded onto this gel .
one ofthe most convenient of these reagents, sodium carbon-
ate (7) .
The procedure was first titrated using a form of p62 that
has been truncated so as to completely lose its transmembrane
and cytoplasmic domains. This mutant is expressed from SFV
d5 cDNA (one of the d-series [9]) which ends with a stop
translation linker 87 base pairs before the region encoding the
transmembrane region of p62 (Garoff, H ., unpublished re-
sults). We expected that a form of p62 which has completely
lost its membrane-binding polypeptide region should give a
measure of the maximum possible difference between the
wild-type p62 and mutant p62s with nonfunctional mem-
brane anchors. Accordingly, microsomal membranes isolated
from COS-7 cells transfected with pLl-SFV-d5 were treated
with carbonate solutions at different pHs between 10.5 and
11 .5 or with NaOH (100mM final concentration) .Themem-
branes were pelleted and the supernatantand pellet monitored
for p62 release by Western blotting. The results (Fig . 4A)
show that following an extraction at pH 10.5, the lumenal
protein (d5) is mostly found (70%) in the membrane pellet
but that with more stringent conditions, the distribution
between pellet and supernatant can be reversed (compare
lanes 1 and 2 with 7 and 8) . This effect is even more dramatic
for the two forms of the capsid protein (shown in the lower
part of the Fig. 4; note also the differential release of the two
capsid forms) . This implies that the assay can be very sensitive
to small changes in a particular protein and therefore ideal
for assaying the A-mutants . The observation that even at pH
11 .5 30% of the d5 form of p62 remains in the membrane
pellet could be accounted for by some aggregation of the
truncated d5 protein . Alternatively, it could suggest the exist-
ence of a weak interaction (hence partial extraction) between
the d5 protein and the cellular membrane . If p62 A-mutants,
in addition to the transmembrane interaction described
above, also display this lumenal interaction (or aggregation),
we would thereforeexpect to release at best70% ofthe protein
in those mutants where the transmembrane binding region
has been destroyed . (It should be noted that a partial extrac-
tion as observed for d5 has been seen formany other proteins
which are not integral to the membrane ; see, for instance,
proteins of the endoplasmic reticulum in reference 7 and
ovalbumin in reference 16 .)
The conditions used in Fig. 4A were then applied to micro-
somes prepared from cells transfected with the two controls,
pLl-SFV-d5 and pL l-SFV-d9, and the three A-mutants in
the d9 form. These experiments are shown as a peroxidase-
stained blot (Fig. 5) . This and another experiment have been
quantitated (Table I) . Greater than 90% ofthe wild-type p62
is retained in the membrane fraction after this treatment, but
30% or less of the d5-p62 is pelleted. The three SFV-A
mutants fall midway between these two extremes, with 30-
40% of the protein being released . The magnitude and direc-
tion of differences between the mutants differ from experi-
ment to experiment and therefore do not appear to be signif-
icant . Thus all three A-mutants are destabilized in the mem-
brane when compared to the wild type .
Discussion
In thispaper, the topology and stability in cellular membranes
ofthree mutants ofthe membrane-binding region ofSFV-E2
have been analyzed . The three mutants have been previously
shown to be associated with the membrane in a functionally
unaltered way (see preceding paper) . Here the nature of that
association has been analyzed .
The topology ofall threeSFV-A mutants ofp62 is unaltered
from wild type . All three span the bilayer, having reagent-
accessible cytoplasmic domains both when expressed as a
complete p62/E1 spike or as p62 alone. The data from both
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Cutler et al . TopologyandMembraneBindingFigure 4 . Membrane binding ofd5 . Four dishes ofCOS-7 cells were transfected with pLl-SFV-d5 ; microsomal fractions were made and mixed
with an equal volume of (A) 200 mM Na carbonate, pH 11 .5 ; (B) 200 mM NaOH ; (C) 200 mM Na carbonate, pH 11 ; or (D) 200 mM Na
carbonate, pH 10.5 . Membranes were pelleted and pellet (P) and supernatant (S) fractions electrophoresed on a 10% SDS polyacrylamide gel .
Protein was transferred to a nitrocellulose filter which was incubated with anti-E2 and anti-capsidantibodies (polyclonal IgG fractions) followed
by peroxidase-conjugated sheep anti-rabbit IgG, and stained with diaminobenzidine/HZ02 . Each pair of tracks equals input from one 5-cm
dish of cells . C indicates nontransfected cells, input from halfofone 5-cm dish .
the protease protection and antibody injection experiments
imply that the topology of the mutants is the same as that of
the wild-type p62 . However, small differences between them
might be beyond the resolution ofthese assays. There are two
problems involved with the protease-protection assay: (a) the
very small percentage shifts in molecular weight to be ana-
lyzed (the wild-type cytoplasmic domain is -5% of unglyco-
sylated p62) ; and (b) the aberrant migratory behaviorresulting
from changes in and around the hydrophobic portion of
transmembrane glycoproteins (e.g ., the aberrant migration of
A2 [discussed in the preceding paper] and of Vesicular Sto-
matitis virus glycoprotein mutants [ 11) . However, within these
limitations it is clear that each mutant has a protease-acces-
sible domain (or tail) that is approximately the same size as
that of wild-type p62 . It is also clear that all molecules ofeach
mutant population have such a tail.
The importance of the COON-terminal region of the p62
protein for membrane binding is clearly shown by the fact
that -70% of the anchorless d5 form can be extracted from
transfected cell membranes with a carbonate buffer at pH
11 .5, whereas p62 with a wild-type membrane-binding region
remains almost quantitatively membrane bound . The intro-
duction into the p62 membrane-binding region of three dif-
ferent point mutations designed to alter either the hydropho-
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bic domain or the charge cluster is shown to significantly
weaken this interaction . This suggests that both of these
features are critical for efficientmembrane binding of the p62
protein . It is possible in theory that the A1, A2, and A3
mutations in the membrane-binding region affect instead the
postulated interaction ofthe lumenal domain with the cellular
membrane, which could account for the behavior of the d5
form of p62 . We find this interpretation unlikely, because it
would require that the interaction between the unaltered
transmembrane domain of p62 and the lipid bilayer would
only be partially (-70%) responsible for membrane anchor-
ing, the rest ofthis function being provided by the postulated
lumenal interaction . Moreover, all integral membrane pro-
teins studied so far show quantitative co-pelleting with the
membranes in such assays (7, 15) .
In summary, and with the reservations discussed above, we
have shown in this and in the preceding paper that the A-
mutants of p62/E2 are all translocated, glycosylated, and
reach the cell surface with similar efficiency to each other and
wild type. Once on the cell surface they are all capable of
promoting qualitatively wild-type cell-cell fusion . The topol-
ogy both in vivo and in vitro of the mutants is indistinguish-
able from that of wild-type p62 but the stability of their
association with the membrane has been reduced .
908Figure 5. Membrane binding of the SFV-A mutants. COS-7 cells (one 5-cm dish/probe) were transfected with the pLI-SFV-d9 plasmid series
(d9, d9A1, d9Á2, d9A3)and pL1-SFV-d5 (d5). Microsomal preparations (cell homogenates) were mixed with an equal volume of Na carbonate,
pH 11.5 ; the membranes were pelleted and supernatant (S) and pellet (P) fractions electrophoresed on a 10% polyacrylamide gel. Protein was
transferred to a nitrocellulose filter which was incubated with an anti-E2 antibody (affinity-purified IgG), then a peroxidase-conjugated sheep
anti-rabbit IgG, and stained with diaminobenzidine/H202 .
Table I. Percentage of Wild-type andMutant p62s Retained
in Cellular Membranes after Carbonate Treatment*
Experiment$
￿
d9
￿
d9A l
￿
d9Á2
￿
d9A3
￿
d5
1§
￿
93 1 67 66 57 21
2
￿
91 63 69 69 32
* Carbonate experiments were quantitated by Western blotting of samples
followed by incubation ofblots with specific antibody followed by '25I-protein
A . Autoradiographs were scanned with a densitometer, peaks cut out, and
weighed.
= Each experiment is a separate series oftransfections .
§ Samples used for this blot are the same as those used in Fig . 5.
Weight of pellet sample expressed as percent of sum of weights of pellet plus
supernatant samples.
Thus our data indicate that, for p62/E2, (a) the hydropho-
bic stretch alone can stop translocation ; (b) the charge cluster
does appear to stabilize the protein-membrane interaction ;
(c) the type and/or number of charged amino acids may well
be important for this function.
Because in the case ofA3 (which appears to have unaltered
topology), the next charged amino acid is 23 amino acids
downstream from the hydrophobic stretch towards the car-
boxy terminus ofE2, we believe that it is unlikely that charge
is involved in arresting the transfer of p62 protein . Recently,
other studies have shown that the deletion of the hydrophobic
stretch, leaving the charge cluster and cytoplasmic domain
intact, leads to loss of anchoring function in Vesicular Sto-
matitis virus glycoprotein (1) and the retroviral oncogene V-
fms (13) . In addition, in a prokaryotic system, Davis and
Model (5) have shown that a synthetic hydrophobic stretch,
inserted into the middle of the gene III protein of phage F1,
can anchor that protein in the membrane . Although in the
latter case the hydrophobic stretch was immediately followed
by a charged amino acid, these results are consistent with our
findings that a hydrophobic stretch is probably sufficient to
cause anchoring of a membrane protein . It follows from this
that the charge cluster is most likely not required as a stop
transfer signal but may have some other role.
Our data suggest that the charge cluster acts as a stabilizing
factor but that not any charged amino acid will fulfill this role
(both A1, with a single Glu and A3, with no change cluster
were both distinguishable from wild-type p62) . The gene III
protein system has also been used to investigate this problem .
Davis et al . (6) have shown that in their membrane-binding
assay, a gene III mutant which has lost its charge cluster(pND
418A) is associated with the membrane in a wild-type fashion .
Unfortunately, since the gene III protein has no large cyto-
plasmic domain, no easy assay for its topology is possible .
Moreover, although under their assay conditions, its mem-
brane-binding capacity is not reduced, it could be that under
more stringent assay conditions pND 418A would be less
stable in the membrane than the wild-type protein . Another
example of a membrane-spanning protein losing its charge
cluster is that of the Friend Spleen Focus-Forming virus
envelope protein gp65 . This protein, initially detected on the
cell surface, is slowly released from infected cells (11) . Thus
the charge cluster may play a role of varying importance in
different proteins, ranging from undetectable through to es-
sential for maintenance (but not necessarily establishment) of
trunsmembrane topology . This may simply reflect the struc-
tures of the individual proteins concerned .
The results obtained with A2 (where a single charged amino
acid has been introduced into themembrane-spanning region)
raise some interesting questions. Since one glutamic acid
alone cannot substitute for the wild-type charge cluster ofE2,
as demonstrated by A1, we might not expect to findA2 (with
a single Glu introduced into the hydrophobic region) an-
chored upstream of its normal position in the membrane.
Our results from the protease-protection experiments (with
the reservations discussed above)concurwith this expectation.
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very short (8 amino acids long) hydrophobic stretch (from the 
charge duster to the introduced Glu). This is of course shorter 
than any natural membrane spanning region, most of which 
are 20 or more amino acids long. This length of 8 may be an 
underestimate since the charged side chain of an amino acid 
could remain outside the bilayer while the backbone is buried 
within  it.  When  the  lengths  of the  side  chains  of charged 
amino acids are taken into account as suggested by von Heijne 
(19),  we reach an effective length of 8(+5) amino acids. To 
obtain  the  figure  of 5  we  have taken  the  largest possible 
estimate by adding the  corrective values suggested by von 
Heijne (19) for the two charged amino acids that border the 
eight hydrophobic amino acids in this case. Other studies have 
also addressed  the question  of whether a  shortened  mem- 
brane-spanning region can still function as an anchor. Studies 
by Adams and Rose published recently (1) suggest that the 
transmembrane topology of the  Vesicular  Stomatitis  virus 
glycoprotein is maintained by a  hydrophobic stretch of 12 
amino acids. Moreover, interrupting the hydrophobic stretch 
of the Vesicular Stomatitis virus glycoprotein with an Arg, 
leaving 11  uninterrupted hydrophobic amino acids, does not 
prevent transmembrane topology from being achieved (2). In 
their studies with the gene III protein, Davis et al. show that 
binding by the natural anchor is gradually lost as the hydro- 
phobic  domain  is  truncated,  being  impaired  at  12  amino 
acids, and lost thereafter (6). Most elegantly, using a synthetic 
linker encoding hydrophobic amino acids inserted into gene 
III  they show that 12 or 14 amino acids, depending on position 
within  the  protein,  are  sufficient  for anchorage to  at least 
some extent (5).  This discussion ignores exactly how hydro- 
phobic each stretch of uncharged amino acids is, or which 
charged amino acids are involved at which boundaries of the 
domain  in  each  case,  and  what  contributions  these  might 
make to the effective span length. However, it does suggest 
that it is possible for a considerably shortened hydrophobic 
stretch to act as an anchor, even if  only in a partially successful 
fashion. It is also of interest that the minimum length require- 
ment for both  pro- and eukaryotic proteins appears to be 
similar. Normal membrane-spanning domains are thought to 
exist as alpha helices (10).  Exactly how these shortened do- 
mains  span  the  bilayer is  not  clear,  possibly either  in  an 
extended structure or by burying the charges at either or both 
ends in the bilayer. In the case of the A2 mutation of p62, the 
region upstream of the introduced Glu is hydrophobic and so 
this might facilitate the latter solution. 
Thus a length of hydrophobic and uncharged amino acids, 
considerably shorter than those spanning regions described in 
wild-type proteins, followed by a charge cluster, can act as an 
anchor. The stretch of hydrophobic amino acids spanning the 
bilayer can also act as an anchor without a following charge 
cluster.  Our  data  concurs  with  that  published  by  others. 
Moreover, we have added  to this  picture by showing in  a 
eukaryotic system that  although  a  full-length  hydrophobic 
stretch without a charge cluster is fully effective as an anchor 
in vivo, it can be distinguished from the wild-type protein by 
a sufficiently stringent assay. We have also shown that a single 
Glu cannot substitute for the dibasic wild-type charge cluster 
of p62. Our results fit a model where (as described recently 
by Davis and Model [5]) the membrane-binding region halts 
translocation mainly by nonspecific (degenerate) hydrophobic 
interactions with the tunnel or the interior of the bilayer. 
A further implication arises from our use of functional as 
well as structural assays; cell surface transport of membrane 
proteins  and  cell-cell  fusion  promoted  by  those  proteins 
apparently do  not  require  precise and  stable  relationships 
between the proteins and the membranes that they are buried 
in. 
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